Feed/Companies/Aragen Life Sciences

Aragen Life Sciences

As of 14 Oct 2026, Aragen Life Sciences has raised $100M across 1 verified round on record; latest: $100 Mn funding round, announced 13 Jan 2025.

BUILT ON

Visit site

Aragen is a fully integrated technology-led CRDMO providing discovery, development, and manufacturing services for small molecules and biologics to pharmaceutical companies.

aragen.comLinkedInHyderabad, India and Singapore

LATEST ROUND

Funding round

$100M · 2025-01-13

RAISED ON RECORD · USD

$100M

across 1 verified round

INVESTORS

no lead named

SOURCES

from 1 publisher

Feed/Companies

Company

Every round on record, with the sources behind each and the investors on them.

BUILT ON

Funding round

$100M · 2025-01-13

at USD 1.4 bn valuation

[ HISTORY ]

lead not stated

Round	Amount	Announced	Lead	Buzz
Funding round [ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$100M at USD 1.4 bn valuation	2025-01-13	not stated	No recent discussion
1 source [ VERIFIED · CORRECTED ] read against 1 source The release does not label a financing stage. Its “Hyderabad, India and Singapore” dateline is not treated as headquarters; Goldman Sachs is identified as an existing strategic investor. Published by hand (aragen.com): "Aragen announced that it has secured a $100 Mn investment from Quadria Capital.": biggest-rounds completeness (K): the row's own page states the round

Aragen Life Sciences

Company

Rounds

Sources

Profile

Investors

Aragen Life Sciences

Rounds

Profile

Sources

Funding round$100M2025-01-131 source

Investors

Funding round$100M2025-01-131 investor